Literature DB >> 15030310

A cell death pathway induced by antibody-mediated cross-linking of CD45 on lymphocytes.

Ann-Muriel Steff1, Marylène Fortin, Fabianne Philippoussis, Sylvie Lesage, Chantal Arguin, Pauline Johnson, Patrice Hugo.   

Abstract

The protein tyrosine phosphatase CD45 is a highly expressed glycoprotein present on all nucleated cells of hematopoietic origin. To date, all the functions attributed to CD45 are inherently coupled to its phosphatase activity. For instance, the regulation of lymphocyte antigen receptor signaling is mediated through the dephosphorylation, and hence activation, of Src-family kinases by CD45. Moreover, signaling via cytokine receptors is negatively modulated by CD45 by dephosphorylation of Janus kinase family members. Recently, another function for CD45, unrelated to regulation of surface receptor signaling, has been unraveled. Specific engagement of CD45 by monoclonal antibodies at the surface of lymphocytes induced their death, through an alternative caspase-independent pathway. In striking contrast to all other previously reported functions for CD45, its phosphatase activity is completely dispensable for the induction of cell death. This article reviews the current knowledge on the death pathway triggered by CD45 ligation on lymphocytes. In an attempt to better elucidate the mechanism of cell death induction through CD45, we also provide original data regarding the susceptibility of various subsets of immature and mature T and B cells to death induced by CD45 engagement. The physiological significance and therapeutic potential of CD45-induced death are also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15030310     DOI: 10.1615/critrevimmunol.v23.i56.40

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  5 in total

1.  Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS).

Authors:  Chui Yee Fong; Gary S L Peh; Kalamegam Gauthaman; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2009-01-31       Impact factor: 5.739

2.  Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.

Authors:  Irene Guendel; Sergey Iordanskiy; Gavin C Sampey; Rachel Van Duyne; Valerie Calvert; Emanuel Petricoin; Mohammed Saifuddin; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

3.  Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage.

Authors:  Eva Pericolini; Elena Gabrielli; Giovanni Bistoni; Elio Cenci; Stefano Perito; Siu-Kei Chow; Francesca Riuzzi; Rosario Donato; Arturo Casadevall; Anna Vecchiarelli
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

4.  Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.

Authors:  Roland B Walter; Kelli M Boyle; Frederick R Appelbaum; Irwin D Bernstein; John M Pagel
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

5.  A non-cytosolic protein of Trypanosoma evansi induces CD45-dependent lymphocyte death.

Authors:  Nicolas Antoine-Moussiaux; Anne Cornet; François Cornet; Stéphanie Glineur; Martin Dermine; Daniel Desmecht
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.